These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 29462715)

  • 1. A new model of diabetic nephropathy in C57BL/6 mice challenged with advanced oxidation protein products.
    Bai X; Li X; Tian J; Xu L; Wan J; Liu Y
    Free Radic Biol Med; 2018 Apr; 118():71-84. PubMed ID: 29462715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced Oxidation Protein Products Aggravate Tubulointerstitial Fibrosis Through Protein Kinase C-Dependent Mitochondrial Injury in Early Diabetic Nephropathy.
    Li X; Xu L; Hou X; Geng J; Tian J; Liu X; Bai X
    Antioxid Redox Signal; 2019 Mar; 30(9):1162-1185. PubMed ID: 29482336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BTBR Ob/Ob mutant mice model progressive diabetic nephropathy.
    Hudkins KL; Pichaiwong W; Wietecha T; Kowalewska J; Banas MC; Spencer MW; Mühlfeld A; Koelling M; Pippin JW; Shankland SJ; Askari B; Rabaglia ME; Keller MP; Attie AD; Alpers CE
    J Am Soc Nephrol; 2010 Sep; 21(9):1533-42. PubMed ID: 20634301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis
    Li X; Zhang T; Geng J; Wu Z; Xu L; Liu J; Tian J; Zhou Z; Nie J; Bai X
    Antioxid Redox Signal; 2019 Sep; 31(7):521-538. PubMed ID: 31084358
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-protein diet supplemented with ketoacids delays the progression of diabetic nephropathy by inhibiting oxidative stress in the KKAy mice model.
    Liu D; Wu M; Li L; Gao X; Yang B; Mei S; Fu L; Mei C
    Br J Nutr; 2018 Jan; 119(1):22-29. PubMed ID: 29208058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of diabetic nephropathy in a transgenic model of hypoinsulinemic diabetes.
    Kanetsuna Y; Hirano K; Nagata M; Gannon MA; Takahashi K; Harris RC; Breyer MD; Takahashi T
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1315-22. PubMed ID: 16705146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semaphorin3a promotes advanced diabetic nephropathy.
    Aggarwal PK; Veron D; Thomas DB; Siegel D; Moeckel G; Kashgarian M; Tufro A
    Diabetes; 2015 May; 64(5):1743-59. PubMed ID: 25475434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy.
    Ninichuk V; Kulkarni O; Clauss S; Anders H-
    Eur J Med Res; 2007 Aug; 12(8):351-5. PubMed ID: 17933712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
    Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced oxidation protein products induce endothelial-to-mesenchymal transition in human renal glomerular endothelial cells through induction of endoplasmic reticulum stress.
    Liang X; Duan N; Wang Y; Shu S; Xiang X; Guo T; Yang L; Zhang S; Tang X; Zhang J
    J Diabetes Complications; 2016; 30(4):573-9. PubMed ID: 26861949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperoside reduces albuminuria in diabetic nephropathy at the early stage through ameliorating renal damage and podocyte injury.
    Zhang J; Fu H; Xu Y; Niu Y; An X
    J Nat Med; 2016 Oct; 70(4):740-8. PubMed ID: 27255369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice.
    Zhao HJ; Wang S; Cheng H; Zhang MZ; Takahashi T; Fogo AB; Breyer MD; Harris RC
    J Am Soc Nephrol; 2006 Oct; 17(10):2664-9. PubMed ID: 16971655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A sensitized screen of N-ethyl-N-nitrosourea-mutagenized mice identifies dominant mutants predisposed to diabetic nephropathy.
    Tchekneva EE; Rinchik EM; Polosukhina D; Davis LS; Kadkina V; Mohamed Y; Dunn SR; Sharma K; Qi Z; Fogo AB; Breyer MD
    J Am Soc Nephrol; 2007 Jan; 18(1):103-12. PubMed ID: 17151334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mouse model of advanced diabetic kidney disease.
    Thibodeau JF; Holterman CE; Burger D; Read NC; Reudelhuber TL; Kennedy CR
    PLoS One; 2014; 9(12):e113459. PubMed ID: 25514595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining streptozotocin and unilateral nephrectomy is an effective method for inducing experimental diabetic nephropathy in the 'resistant' C57Bl/6J mouse strain.
    Uil M; Scantlebery AML; Butter LM; Larsen PWB; de Boer OJ; Leemans JC; Florquin S; Roelofs JJTH
    Sci Rep; 2018 Apr; 8(1):5542. PubMed ID: 29615804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathology of human diabetic nephropathy.
    Najafian B; Alpers CE; Fogo AB
    Contrib Nephrol; 2011; 170():36-47. PubMed ID: 21659756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal pathological implications in type 2 diabetes mellitus patients with renal involvement.
    Li L; Zhang X; Li Z; Zhang R; Guo R; Yin Q; Yang L; Yue R; Su B; Huang S; Xu H; He C; Liu F
    J Diabetes Complications; 2017 Jan; 31(1):114-121. PubMed ID: 27838100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loganin attenuates diabetic nephropathy in C57BL/6J mice with diabetes induced by streptozotocin and fed with diets containing high level of advanced glycation end products.
    Liu K; Xu H; Lv G; Liu B; Lee MK; Lu C; Lv X; Wu Y
    Life Sci; 2015 Feb; 123():78-85. PubMed ID: 25623853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Higher Advanced Oxidation Protein Products (AOPPs) Levels in Patients with Diabetic and Hypertensive Nephropathy.
    Conti G; Caccamo D; Siligato R; Gembillo G; Satta E; Pazzano D; Carucci N; Carella A; Campo GD; Salvo A; Santoro D
    Medicina (Kaunas); 2019 Oct; 55(10):. PubMed ID: 31591338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.